Live

biopharma

3 articles

Insider Selling as a Contrarian Signal: Why $WM and $IONS Merit Investor Attention

Investing.com

Investing.com·10h ago·Thomas Hughes

Insider Selling as a Contrarian Signal: Why $WM and $IONS Merit Investor Attention

Insider selling at $WM and $IONS masks attractive opportunities as institutional accumulation and strong fundamentals validate contrarian bullish cases for both stocks.

WMIONSdividend growthprofit-taking

ImmunityBio Surges 11% on First Asian Approval for Bladder Cancer Drug

The Motley Fool

The Motley Fool·1d ago·James Brumley

ImmunityBio Surges 11% on First Asian Approval for Bladder Cancer Drug

ImmunityBio stock surged 11.2% after Macau approved its bladder cancer drug Anktiva, marking the company's first Asian regulatory victory and potential gateway for regional expansion.

IBRXAsia-Pacific expansionbladder cancer

Three Cash Flow Powerhouses Offer Shelter Amid Market Uncertainty

Investing.com

Investing.com·Mar 6·Nathan Reiff

Three Cash Flow Powerhouses Offer Shelter Amid Market Uncertainty

Three firms—Gilead Sciences, AbbVie, and Visa—offer defensive portfolios substantial free cash flow yields and capital returns amid 2026 market uncertainty.

VABBVGILDdividendpayments